Racket manufacturing fake medicines busted, factory owner held

Written By : Ruchika Sharma |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2025-07-19T17:05:29+05:30 | Updated On 19 July 2025 5:05 PM IST

Dehradun: The owner of Dr Mittal Laboratories, which manufactured fake medicines by copying products of reputed pharmaceutical companies, was arrested on Friday in Uttarakhand.

Devi Dayal Gupta, who had been absconding for a long time, was finally tracked down and arrested in Dehradun by the Uttarakhand Special Task Force (STF), Senior Superintendent of Police (STF) Navneet Singh Bhullar said.

Gupta is a resident of Ashok Vihar Phase-2, Delhi. His arrest brings the total number of accused in the case to four, including the kingpin of the operation, he said.

On June 1, an accused, Santosh Kumar, was caught in the Selaqui area with a large quantity of fake packaging boxes, labels and QR codes of wrappers of medicines of leading companies such as Glenmark, Ipca Laboratories, Intas Pharma, Alkem Health Science, Dr Reddy’s Laboratories and Cadila Pharmaceuticals, the SSP said.

Later, the STF arrested the kingpin Naveen Bansal and another accused, Aditya Kala. During Bansal’s interrogation, he revealed that fake medicines were made in Gupta’s factory in Sahaspur area and sent to places including Haryana and Rajasthan, Bhullar said.

From 2021 until the case came to light this year, Gupta allegedly manufactured 1.42 crore tablets and around two lakh capsules, which were supplied to Bansal’s fake firms -- Reelin Pharmatech and B Chem Biotech. These were then packed in wrappers of reputed brands and distributed to several cities across north India, PTI reported.

The fake drugs included Pantoprazole 40, Diclosin SP, Levocetirizine, Prochlorperazine, Amlodipine and Telmisartan tablets, the STF said.

dr mittal labsglenmarkipca labsintas pharmaalkem health sciencedr reddys labscadila pharmapantoprazole 40diclosin SPlevocetirizineprochlorperazineamlodipinetelmisartan tabletsReelin PharmatechB Chem Biotech

Source : with inputs

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751